Skip to main content

Table 4 Differentiation between male and female diabetic children (8–12 years) and adolescents (13–18 years) concerning their PedsQL™ 4.0 Generic Core Scales (GCS) and PedsQL™ 3.0 Diabetic Module

From: Health-related quality of life in a group of Egyptian children and adolescents with type 1 diabetes: relationship to microvascular complications

Functioning scale No. of items Diabetic male children (8–12 years) n = 12
Mean ± SD
Range
Diabetic female children (8–12 years) n = 12
Mean ± SD
Range
Independent t test Diabetic male adolescents (13–18 years) n = 10
Mean ± SD
Range
Diabetic female adolescents (13–18 years) n = 26
Mean ± SD
Range
Independent t test
t p value t p value
PedsQL™ 4.0 Generic Core Scales
 Total score 23 79.55 ± 14.50 74.55 ± 14.85 0.834 0.413 70.56 ± 11.47 61.99 ± 15.09 1.619 0.115
53.41–100 40.22–94.57 (50–84.09) (35.87–92.39)
 Physical health 8 82.33 ± 13.08 77.81 ± 17.00 0.730 0.474 70.22 ± 13.07 65.27 ± 16.44 0.852 0.400
56.25–100 40.63–100 (45.83–84.38) (37.5–96.88)
 Emotional functioning 5 73.85 ± 17.08 66.77 ± 15.02 1.079 0.293 65.38 ± 13.39 52.50 ± 16.69 2.406 0.026*
45–100 35–90 (40–80) (25–85)
 Social functioning 5 83.75 ± 14.32 78.96 ± 13.63 0.840 0.410 79.75 ± 8.54 63.56 ± 15.6 3.092 0.004**
50–100 45–95 (65–90) (35–90)
 School functioning 5 77.08 ± 17.12 71.88 ± 14.58 0.802 0.431 66.13 ± 13.00 65.29 ± 14.17 0.162 0.872
45–100 40–100 (43.75–85) (35–95)
 Psychosocial health 15 78.26 ± 15.70 72.82 ± 14.17 0.892 0.382 70.68 ± 10.98 60.41 ± 14.82 1.983 0.055
46.67–100 40–91.67 (51.67–83.93) (35–90)
PedsQL™ 3.0 Diabetic Module
 total score 28 76.12 ± 15.39 69.25 ± 15.89 1.076 0.294 65.60 ± 12.29 58.69 ± 15.93 1.233 0.226
50–97.32 37.04–88.39 (41.35–75.93) (29.63–87.96)
 Diabetes symptoms 11 72.86 ± 16.66 67.52 ± 17.12 0.775 0.447 63.18 ± 16.06 57.91 ± 17.00 0.846 0.403
45.45–93.18 31.82–84.1 (31.82–79.55) (25–86.36)
 Treatment barriers 4 70.31 ± 19.61 63.19 ± 16.05 0.973 0.341 61.04 ± 10.72 55.69 ± 16.28 0.958 0.345
43.75–100 37.5–87.5 (41.66–68.75) (31.25–87.5)
 Treatment adherence 7 82.54 ± 13.41 76.19 ± 15.25 1.083 0.290 67.86 ± 11.17 65.93 ± 14.44 0.379 0.707
57.14–100 46.43–100 (42.86–78.57) (32.14–89.29)
 Worry 3 76.39 ± 15.52 64.93 ± 19.01 1.617 0.120 69.58 ± 10.02 50.64 ± 19.25 2.944 0.006**
41.67–100 25–91.67 (50–83.33) (16.67–87.5)
 Communication 3 81.60 ± 13.35 70.83 ± 13.99 1.928 0.067 71.67 ± 10.72 56.09 ± 18.11 3.172 0.004**
58.33–100 41.67–83.33 (50–87.5) (16.67–91.67)